We write in relation to your article "British firm accused of supplying poor-quality drugs to Kyrgyzstan" (4 March 2013) relating to Rotapharm and the medicine Repretin. Both Rotapharm Limited (registered no. 05596694) and World Medicien Limited (registered no. 5285227) were incorporated in the UK under the Companies Act 1985 (Rotapharm in 2005, World Medicine in 2004). Both companies are registered taxpayers in the UK. They meet their tax liabilities in full and are audited on a regular basis. Mr Raushan Tahiyeu is also a UK taxpayer. Repretin is manufactured in Eygpt and was registered in Kyrgyz Republic in 2009. In addition, it has been registered in other territories of other CIS countries. Rotapharm is the exclusive supplier of Repretin to the CIS countries but has no representative office in Kyrgyz Republic, contracting with local distributors. Marketing is conducted in Kyrgyz Republic by the distributing companies that import the medicines. In February 2013 questions were raised over Repretin. However, all the distributing companies which have imported and sold Repretin in Kyrgyz Republic have been audited by the relevant Kyrgyz authorities pursuant to parliamentary commission request. They had not revealed any violations. After the allegations against Repretin came to light, samples were sent to the Kyrgyz ministry of health to an independent laboratory for analysis. That laboratory has confirmed the quality and safety of Repretin. The Kyrgyz ministry of health has now set the record straight.
Rotapharm Limited and Raushan Tahiyeu
Read more here >> The Guardian | Quail eggs
